Confidentiality Issues Impact Use of STD Services for Youth

Share this content:
Confidentiality Issues Impact Use of STD Services for Youth
Confidentiality Issues Impact Use of STD Services for Youth

MONDAY, March 13, 2017 (HealthDay News) -- For adolescents and young adults, confidentiality-related concerns are associated with less use of sexually transmitted disease (STD) services, according to a report published in the March 10 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Jami S. Leichliter, Ph.D., from the CDC in Atlanta, and colleagues examined use of STD services and confidentiality-related issues among persons aged 15 to 25 years using data from the 2013 to 2015 National Survey of Family Growth.

The researchers found that 12.7 percent of sexually experienced youths on their parent's insurance plan would not seek sexual and reproductive health care due to concerns that their parents might find out. Those aged 15 to 17 years were particularly concerned (22.6 percent). Compared to females without concerns, those with confidentiality concerns regarding seeking sexual and reproductive health care reported a lower prevalence of receipt of chlamydia screening (17.1 versus 38.7 percent). Compared to adolescents aged 15 to 17 years who did not spend time alone with a health care provider (without a parent in the room), those who did spend time alone reported higher receipt of a sexual risk assessment (71.1 versus 36.6 percent), and, among females, chlamydia testing (34.0 versus 14.9 percent).

"The results indicated that confidentiality-related issues were associated with less reported use of some STD services, especially for younger persons and females," the authors write.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »